Month: November 2016
-
Patent Awarded for Cancer-Fighting Antibody
A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Lilly, Institute Partner on Tuberculosis Drug Discovery
Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis.
-
Health Insurance Group Forms Academic Research Network
The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings.
-
Safety, Effects Shown in Drug Clearing Alzheimer’s Peptides
An experimental drug that clears peptides associated with Alzheimer’s disease from the central nervous system was also shown to be safe for patients in an early clinical trial.
-
Synthetic Virus Created to Treat Cancer in Dogs
Two companies partnering with Auburn University developed a synthetic virus to find and destroy tumor cells in a type of bone cancer in dogs.
-
Gene Therapy Shown Helpful with Inherited Skin Disease
An early clinical trial shows genetically engineered skin grafts help heal some open wounds and appear safe for individuals with a serious inherited skin disorder.
-
Clinic Opens for Engineered T-Cell Cancer Therapies
A clinic to provide cancer treatments that use a patient’s immune system cells engineered to fight cancer is open at the Fred Hutchinson Cancer Research Center in Seattle.
-
Spinach Enhanced to Detect Chemicals, Send Signals
A chemical engineering group showed the feasibility of embedding sensors in common spinach plants that can detect and signal the presence of explosive chemicals in the soil.